Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
INSULIN Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2026 · third_quarter · Q3
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
Source: Senate LDA
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
PAAT Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
PAAT Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
Consolidated Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R.7148 - Consolidated Appropriations Act, 2026
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
SCREEN for Type 1 Diabetes Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
SCREEN for Type 1 Diabetes Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
Military Next-Gen Collision Avoidance Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
Military Next-Gen Collision Avoidance Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
Relief of Chronic Pain Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
INSULIN Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
INSULIN Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
INSULIN Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
SCREEN for Type 1 Diabetes Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
SCREEN for Type 1 Diabetes Act of 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 1 - One Big Beautiful Bill H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, FY 2026 Issues pertaining to NIH research funding
Medical Device Electronic Labeling Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues pertaining to NIH research funding Issues pertaining to Medicare coverage of AID and CGM systems H.R. 919, the Chronic Disease Flexible Coverage Act H.R. 1539, the Medical Device Electronic Labeling Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues pertaining to NIH research funding H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025
Expanding Access to Diabetes Self-Management Training Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 1 - One Big Beautiful Bill H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, FY 2026 Issues pertaining to NIH research funding
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
PAAT Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
Special Diabetes Program for Indians Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
Special Diabetes Program for Indians Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Chronic Disease Flexible Coverage Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues pertaining to NIH research funding Issues pertaining to Medicare coverage of AID and CGM systems H.R. 919, the Chronic Disease Flexible Coverage Act H.R. 1539, the Medical Device Electronic Labeling Act
Expanding Access to Diabetes Self-Management Training Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
American Relief Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10545 - American Relief Act of 2025. H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Good Jobs for Good Airports Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Good Jobs for Good Airports Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
Chronic Disease Flexible Coverage Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
Accelerating Kids’ Access to Care Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Lower Costs, More Transparency Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 10545 - American Relief Act of 2025. H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Extension of Continuing Appropriations and Other Matters Act, 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
INSULIN Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Legislative outreach and monitoring related to insulin affordability. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023.
INSULIN Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
INSULIN Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
INSULIN Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Accelerating Kids’ Access to Care Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Government Surveillance Reform Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Affordable Insulin Now Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Affordable Insulin Now Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
Insulin for All Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues related to prescription drug pricing, particularly as it relates to insulin S. 146 - Cap Insulin Prices Act HR 1488/S. 954 - Affordable Insulin Now Act H.R. 1485 - Insulin for All Act of 2023 H.R.1587 - Making Insulin Affordable for All Children Act Issues related to the Special Diabetes Program renewal
Affordable Insulin Now Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues related to prescription drug pricing, particularly as it relates to insulin S. 146 - Cap Insulin Prices Act HR 1488/S. 954 - Affordable Insulin Now Act H.R. 1485 - Insulin for All Act of 2023 H.R.1587 - Making Insulin Affordable for All Children Act Issues related to the Special Diabetes Program renewal
Affordable Insulin Now Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4420 - Preparedness and Response Reauthorization Act H.R. 3561 - PATIENT Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 S. 954/H.R. 1488 - Affordable Insulin Now Act H.R. 4758/S. 2372 - Accelerating Kids Access to Care Act S.2205/H.R. 4304 - The ISLET Act Issues related to Medicare and Medicaid
Affordable Insulin Now Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2547 - Special Diabetes Program for Indians Reauthorization Act of 2023 H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 1488 - Affordable Insulin Now Act S. 954 - Affordable Insulin Now Act H.R. 3561 - PATIENT Act of 2023 Issues related to insulin affordability Issues related to collection of race and ethnicity data Issues related to Medicare and Medicaid Issues related to preventative care
Making Insulin Affordable for All Children Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues related to prescription drug pricing, particularly as it relates to insulin S. 146 - Cap Insulin Prices Act HR 1488/S. 954 - Affordable Insulin Now Act H.R. 1485 - Insulin for All Act of 2023 H.R.1587 - Making Insulin Affordable for All Children Act Issues related to the Special Diabetes Program renewal
Special Diabetes Program for Indians Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2547 - Special Diabetes Program for Indians Reauthorization Act of 2023 H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 1488 - Affordable Insulin Now Act S. 954 - Affordable Insulin Now Act H.R. 3561 - PATIENT Act of 2023 Issues related to insulin affordability Issues related to collection of race and ethnicity data Issues related to Medicare and Medicaid Issues related to preventative care
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2547 - Special Diabetes Program for Indians Reauthorization Act of 2023 H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 1488 - Affordable Insulin Now Act S. 954 - Affordable Insulin Now Act H.R. 3561 - PATIENT Act of 2023 Issues related to insulin affordability Issues related to collection of race and ethnicity data Issues related to Medicare and Medicaid Issues related to preventative care
PATIENT Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2547 - Special Diabetes Program for Indians Reauthorization Act of 2023 H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 1488 - Affordable Insulin Now Act S. 954 - Affordable Insulin Now Act H.R. 3561 - PATIENT Act of 2023 Issues related to insulin affordability Issues related to collection of race and ethnicity data Issues related to Medicare and Medicaid Issues related to preventative care
PATIENT Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4420 - Preparedness and Response Reauthorization Act H.R. 3561 - PATIENT Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 S. 954/H.R. 1488 - Affordable Insulin Now Act H.R. 4758/S. 2372 - Accelerating Kids Access to Care Act S.2205/H.R. 4304 - The ISLET Act Issues related to Medicare and Medicaid
Expanding Access to Diabetes Self-Management Training Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Legislative outreach and monitoring related to insulin affordability. H.R. 5378 - Lower Costs, More Transparency Act. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023. S.2205/H.R. 4304 - The ISLET Act. S. 1832 / H.R. 3842 - Expanding Access to Diabetes Self-Management Training Act.
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4420 - Preparedness and Response Reauthorization Act H.R. 3561 - PATIENT Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 S. 954/H.R. 1488 - Affordable Insulin Now Act H.R. 4758/S. 2372 - Accelerating Kids Access to Care Act S.2205/H.R. 4304 - The ISLET Act Issues related to Medicare and Medicaid
ISLET Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Legislative outreach and monitoring related to insulin affordability. H.R. 5378 - Lower Costs, More Transparency Act. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023. S.2205/H.R. 4304 - The ISLET Act. S. 1832 / H.R. 3842 - Expanding Access to Diabetes Self-Management Training Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2624/H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5860 - Continuing Appropriations Act, 2024 and Other Extensions Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Issues related to NIH & ARPA-H Funding S. 2131/H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024
Preparedness and Response Reauthorization Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4420 - Preparedness and Response Reauthorization Act H.R. 3561 - PATIENT Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 S. 954/H.R. 1488 - Affordable Insulin Now Act H.R. 4758/S. 2372 - Accelerating Kids Access to Care Act S.2205/H.R. 4304 - The ISLET Act Issues related to Medicare and Medicaid
Accelerating Kids’ Access to Care Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4420 - Preparedness and Response Reauthorization Act H.R. 3561 - PATIENT Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 S. 954/H.R. 1488 - Affordable Insulin Now Act H.R. 4758/S. 2372 - Accelerating Kids Access to Care Act S.2205/H.R. 4304 - The ISLET Act Issues related to Medicare and Medicaid
Lower Costs, More Transparency Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 4420 - Preparedness and Response Reauthorization Act H.R. 3561 - PATIENT Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 S. 954/H.R. 1488 - Affordable Insulin Now Act H.R. 4758/S. 2372 - Accelerating Kids Access to Care Act S.2205/H.R. 4304 - The ISLET Act Issues related to Medicare and Medicaid
Lower Costs, More Transparency Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Legislative outreach and monitoring related to insulin affordability. H.R. 5378 - Lower Costs, More Transparency Act. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023. S.2205/H.R. 4304 - The ISLET Act. S. 1832 / H.R. 3842 - Expanding Access to Diabetes Self-Management Training Act.
Continuing Appropriations Act, 2024 and Other Extensions Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2624/H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5860 - Continuing Appropriations Act, 2024 and Other Extensions Act
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 2624/H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5860 - Continuing Appropriations Act, 2024 and Other Extensions Act
Further Continuing Appropriations and Other Extensions Act, 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024. Advocacy for inclusion of Special Diabetes Program funding.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2026 · second_quarter · Q2
S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2026 · first_quarter · Q1
H.R.7148 - Consolidated Appropriations Act, 2026
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2025 · fourth_quarter · Q4
H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2025 · third_quarter · Q3
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 3826 / S. 1925 - Expanding Access to Diabetes Self-Management Training Act of 2025 Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce Issues pertaining to insulin affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2025 · second_quarter · Q2
H.R. 1 - One Big Beautiful Bill H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, FY 2026 Issues pertaining to NIH research funding
Issues pertaining to NIH research Issues pertaining to Medicare coverage of AID and CGM systems Issues pertaining to pre-deductible coverage of chronic disease treatments in high-deductible health plans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2025 · first_quarter · Q1
Issues pertaining to NIH research funding H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025
Issues pertaining to NIH research funding Issues pertaining to Medicare coverage of AID and CGM systems H.R. 919, the Chronic Disease Flexible Coverage Act H.R. 1539, the Medical Device Electronic Labeling Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2024 · fourth_quarter · Q4
H.R. 10545 - American Relief Act of 2025. H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023. S. 1269 - INSULIN Act of 2023. H.R. 4758/S.2372 - Accelerating Kids Access to Care Act (AKAC). S. 3234 - Chronic Disease Flexible Coverage Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2024 · third_quarter · Q3
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2024 · second_quarter · Q2
H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2024 · first_quarter · Q1
Legislative outreach and monitoring related to insulin affordability. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023.
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2023 · fourth_quarter · Q4
H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024. Advocacy for inclusion of Special Diabetes Program funding.
Legislative outreach and monitoring related to insulin affordability. H.R. 5378 - Lower Costs, More Transparency Act. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023. S.2205/H.R. 4304 - The ISLET Act. S. 1832 / H.R. 3842 - Expanding Access to Diabetes Self-Management Training Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2023 · third_quarter · Q3
S. 2624/H.R. 5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5860 - Continuing Appropriations Act, 2024 and Other Extensions Act
H.R. 4420 - Preparedness and Response Reauthorization Act H.R. 3561 - PATIENT Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 S. 954/H.R. 1488 - Affordable Insulin Now Act H.R. 4758/S. 2372 - Accelerating Kids Access to Care Act S.2205/H.R. 4304 - The ISLET Act Issues related to Medicare and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2023 · second_quarter · Q2
Issues related to NIH & ARPA-H Funding S. 2131/H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024
H.R. 2547 - Special Diabetes Program for Indians Reauthorization Act of 2023 H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 1488 - Affordable Insulin Now Act S. 954 - Affordable Insulin Now Act H.R. 3561 - PATIENT Act of 2023 Issues related to insulin affordability Issues related to collection of race and ethnicity data Issues related to Medicare and Medicaid Issues related to preventative care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2023 · first_quarter · Q1
Issues related to funding for the National Institutes of Health and the U.S. Food and Drug Administration
Issues related to prescription drug pricing, particularly as it relates to insulin S. 146 - Cap Insulin Prices Act HR 1488/S. 954 - Affordable Insulin Now Act H.R. 1485 - Insulin for All Act of 2023 H.R.1587 - Making Insulin Affordable for All Children Act Issues related to the Special Diabetes Program renewal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2022 · fourth_quarter · Q4
H.R. 2617, the Consolidated Appropriations Act, 2023 Issues related to HHS/NIH/FDA funding
Issues related to prescription drug pricing, particularly as it relates to insulin S. 4446, Modernizing the Accelerated Approval Pathway Act of 2022 H.R. 6963, Accelerated Approval Integrity Act of 2022 H.R. 4128/S. 2209, VALID Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2022 · third_quarter · Q3
H.R. 5376 - Inflation Reduction Act of 2022 H.R. 8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023 H.R. 4356 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023 H.R. 6833 - Making continuing appropriations for Fiscal Year 2023, and for other purposes
Issues related to prescription drug pricing, particularly as it relates to insulin Issues related to coverage of preventive services Issues related to clinical trial diversity H.R.6963 - Accelerated Approval Integrity Act of 2022 S. 4446 - The Modernizing the Accelerated Approval Pathway Act of 2022 H.R. 3089/ S. 1544 - The Accelerating Kids Access to Care Act (AKACA) H.R. 6833/ S. 3700 - Affordable Insulin Now Act H.R. 7667 - Food and Drug Amendments of 2022 S. 4348 - FDASLA Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2022 · second_quarter · Q2
H.R. 4356 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022 H.R. 8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023 Issues pertaining to budget reconciliation
H.R. 5585 - Advanced Research Projects Agency - Health H.R. 6000 - Cures 2.0 Act H.R. 6833 - Affordable Insulin Now Act H.R. 6963 - Accelerated Approval Integrity Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022 Issues related to prescription drug pricing, particularly as it relates to insulin S. 3700 - Affordable Insulin Now Act S. 3819 - ARPA-H Act S. 4348 - FDASLA Act of 2022 S. 4446 - The Modernizing the Accelerated Approval Pathway Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2022 · first_quarter · Q1
H.R.5376 - Build Back Better Act Labor-HHS Appropriations Agriculture-FDA Appropriations H.R. 6617-Further Additional Extending Government Funding Act H.R. 2471- the Consolidated Appropriations Act,2022 Issues related to HHS/NIH/FDA funding
Issues related to prescription drug pricing, particularly as it relates to insulin Issues related to the FDA Accelerated Approval Program H.R. 19 - Lower Costs, More Cures Act of 2021 H.R. 6000 - Cures 2.0 Act H.R. 5585 - Advanced Research Projects Agency - Health H.R. 6833 - Affordable Insulin Now Act S. 3700 - Affordable Insulin Now Act S. 3819 - ARPA-H Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2021 · fourth_quarter · Q4
Issues related to prescription drug pricing, particularly as it relates to insulin H.R. 6000 - Cures 2.0 Act H.R. 5585 - Advanced Research Projects Agency - Health H.R. 5030/S.2706 - DIVERSE Trials Act Issues related to FDA Leadership
H.R. 5376 - Build Back BetterAct H.R. 6119 - Further Extending Government Funding Act Labor-HHS Appropriations Agriculture-FDA Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2021 · third_quarter · Q3
S. 289/H.R. 869 - RISE Act of 2021 Issues related to prescription drug pricing, particularly as it relates to insulin Issues and legislation related to providing (during the COVID-19 emergency period) and preserving (post the COVID-19 emergency period) telehealth/telemedicine flexibilities for individuals with type 1 diabetes Issues related to the creation of the Advanced Research Projects Agency for Health (ARPA-H) H.R. 3437 Long-term Opportunities for Advancing New Studies (LOANS) for Biomedical Research Act
Issues related to budget reconciliation H.R. 4502 - Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 H.R. 4356/S. 2599 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2021 · second_quarter · Q2
S. 289/H.R. 869 - RISE Act of 2021 Issues related to drug pricing, particularly as it relates to insulin Issues related to the importance of preserving health insurance protections for individuals with pre-existing conditions Issues and legislation related to providing (during the COVID-19 emergency period) and preserving (post the COVID-19 emergency period) telehealth/telemedicine flexibilities for individuals with type 1 diabetes Issues related to surprise medical billing H.R. 3437 Long-term Opportunities for Advancing New Studies (LOANS) for Biomedical Research Act S. 2164/H.R. 19 - Lower Costs, More Cures Act of 2021 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
Issues related to appropriations for HHS, NIH, FDA, and CDC
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE